Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.
about
Activities of a new oral streptogramin, XRP 2868, compared to those of other agents against Streptococcus pneumoniae and haemophilus speciesEvaluation of the Dade MicroScan MICroSTREP antimicrobial susceptibility testing panel with selected Streptococcus pneumoniae challenge strains and recent clinical isolates.Extremely high prevalence of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among children in Kaohsiung, Taiwan.Antipneumococcal activities of levofloxacin and clarithromycin as determined by agar dilution, microdilution, E-test, and disk diffusion methodologies.Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media.Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agentsEfficacy of trovafloxacin against penicillin-susceptible and multiresistant strains of Streptococcus pneumoniae in a mouse pneumonia model.Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococciAntibiotic susceptibility patterns of Streptococcus pneumoniae in china and comparison of MICs by agar dilution and E-test methods.In vitro selection of resistance to four beta-lactams and azithromycin in Streptococcus pneumoniaeDocumentation of the prevalence of penicillin-resistant Streptococcus pneumoniae isolated from the middle ear and sinus fluid of children undergoing tympanocentesis or sinus lavage.Antimicrobial resistance in gram-positive bacteria: the myth of the MIC. Minimum inhibitory concentration.Antibiotic resistant Streptococcus pneumoniae.Community acquired infections and bacterial resistance.Population-based survey of antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae from meningitis patients in Salvador, BrazilComparison of agar dilution, microdilution, E-test, and disk diffusion methods for testing activity of cefditoren against Streptococcus pneumoniaeLumbar vertebral osteomyelitis with mycotic abdominal aortic aneurysm caused by highly penicillin-resistant Streptococcus pneumoniae.Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologiesUse of an oxacillin disk screening test for detection of penicillin- and ceftriaxone-resistant pneumococciBacteremic pneumonia caused by a single clone of Streptococcus pneumoniae with different optochin susceptibilitiesEfficacy of high-dose amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniaePostantibiotic effects of grepafloxacin compared to those of five other agents against 12 gram-positive and -negative bacteria.Antipneumococcal activities of gemifloxacin compared to those of nine other agentsNasal carriage in Vietnamese children of Streptococcus pneumoniae resistant to multiple antimicrobial agentsPharmacokinetics of a fluoronaphthyridone, trovafloxacin (CP 99,219), in infants and children following administration of a single intravenous dose of alatrofloxacin.Antipneumococcal activity of ABT-773 compared to those of 10 other agents.Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.Capsular serotype and antibiotic resistance of Streptococcus pneumoniae isolates in two Chilean citiesInfluence of patient age on Streptococcus pneumoniae serotypes causing invasive disease.Antistreptococcal activity of telithromycin compared with seven other drugs in relation to macrolide resistance mechanisms in Russia.Comparative activities of the oxazolidinone AZD2563 and linezolid against selected recent North American isolates of Streptococcus pneumoniae.Prevalence of antimicrobial drug-resistant Streptococcus pneumoniae in Washington State.Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infectionAntimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States.Development of a model of low-inoculum Streptococcus pneumoniae intrapulmonary infection in infant rats.Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the EuDevelopment and evaluation of pneumococcal conjugate vaccines: clinical trials and control tests.Resistance among Streptococcus pneumoniae: Implications for drug selection.Low-level resistance to rifampin in Streptococcus pneumoniaeRisk assessment in regulatory policy making for human and veterinary public health.
P2860
Q24564933-F063F075-5995-42CF-A9BD-B691DC47EDDFQ33659832-9191DBEF-568B-4A2F-B92E-1CA46F0BC3D5Q33672446-65A796A1-E083-47D0-9446-2DEBB601F770Q33685617-4E97F9B6-52B2-4685-94D2-86753A2F86C4Q33691073-59031AB9-317F-40FC-B267-EE7076F3D366Q33691239-6EEFE73C-184E-46AF-A5FB-D113345CAE15Q33692694-BFB7C20A-E44D-4EBA-A2F1-9750D9118674Q33696032-E7B7C332-C1BE-4151-A949-568ACB87DB14Q33699406-6A8C5639-A4AD-4813-8B93-FA499ED332A9Q33701390-900964D0-16F0-41F5-A955-1BFA562D7F7FQ33704509-2C8CFF67-DFF9-4E32-9FB6-B30EB7A61247Q33717162-C867B135-B4CA-48A7-B670-345003D0DD53Q33776122-64765DEF-7DF9-4307-87B4-58565C013CD8Q33791797-7E8638E3-99D8-4204-B1B2-0F26D5DE2CCEQ33946170-D4E8456B-00BF-4FA3-B0C8-EC2FED8D6E9DQ33963021-DBB1B7FC-525C-46B7-A5B6-063614509F9FQ33964464-585A7904-6BEC-41C4-B6C1-A820FBAA0ABFQ33966371-12F1B9D6-888E-41DC-BF4A-A2F4C8BFD74AQ33974710-E6EE6B2E-9F8F-4572-B469-4AB02CAFE091Q33975011-5BD5D76B-AF1F-4E47-8A11-90964CF3BBB0Q33975838-EA4F9ECF-8FE0-454D-BA46-F90E65A1648EQ33978553-CACB6DB3-10CD-46FF-9090-B3C7E91A2F19Q33978679-BFF3EFB1-DE45-4EA3-9A0E-99FC1F8635C1Q33978872-CA20929F-59FE-487B-82FE-31EE57E835AFQ33979388-2231CF89-A6C5-405F-A2D6-93F7E3144634Q33980037-8FD0C423-6962-4A4A-AEED-EB4574130F22Q33982211-DA14B0FF-0CFB-4EB9-A882-B8EF1B3ECA4AQ33991415-4C925BC8-8B9D-434C-9180-6441A02F044CQ33999119-41CB8217-CDD5-4C17-8AA5-942C4B89028AQ34112023-BB9E7648-19C3-4FE0-9431-A2949A21E987Q34112225-FCA7A9B5-E67E-4555-8090-BF4796270B0BQ34189923-90A23124-F569-498C-991E-18452A4052F0Q34223608-E419A97A-AC39-4E7B-A0BA-1BDC4BAD5E82Q34347889-B5113E68-9CF2-4D95-8B58-7DB267411FDFQ34444527-EF7E7534-FE5D-46B2-BE36-EA42B0819D55Q34611253-37A65A4C-2C14-40D2-86E4-7E12B39FE0DBQ34632848-0F41C93F-2CE8-4AC1-A293-9805391B29CBQ34658646-FD6009B6-A00C-433A-92BF-D39F8D3B85FCQ34734752-A8087F74-4698-472E-ADC3-39DA0289AE30Q34773917-75A3CA05-A1A4-4E20-BCFC-D0B9A61D28A8
P2860
Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.
@en
type
label
Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.
@en
prefLabel
Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.
@en
P1476
Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.
@en
P2093
Friedland IR
McCracken GH Jr
P304
P356
10.1056/NEJM199408113310607
P407
P577
1994-08-01T00:00:00Z